ENSYSCE BIOSCIENCES, INC. Debt Instrument, Interest Rate, Effective Percentage
ENSYSCE BIOSCIENCES, INC. (ENSC) had Debt Instrument, Interest Rate, Effective Percentage of 8.00% as of 2023-12-31, per its 10-K filed 2024-03-15.
Discontinued › Notes › Debt › Debt Instruments
us-gaap:DebtInstrumentInterestRateEffectivePercentage · last filed 2024-03-15
- 2023-12-31: Debt Instrument, Interest Rate, Effective Percentage 8.00%.
- 2023-09-30: Debt Instrument, Interest Rate, Effective Percentage 8.00%.
- 2023-06-30: Debt Instrument, Interest Rate, Effective Percentage 8.00%.
- 2023-03-31: Debt Instrument, Interest Rate, Effective Percentage 8.00%.
| Period end | Debt Instrument, Interest Rate, Effective Percentage |
|---|---|
| 2023-12-31 | 8.00% 10-K · filed 2024-03-15 |
| 2023-09-30 | 8.00% 10-Q · filed 2023-11-09 |
| 2023-06-30 | 8.00% 10-Q · filed 2023-08-11 |
| 2023-03-31 | 8.00% 10-Q · filed 2023-05-15 |
| 2022-12-31 | 8.00% 10-K · filed 2024-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |